Luckily, the two Americans who received ZMapp, the new experimental drug for Ebola, seem to be improving, which holds great promise and hope for thousands of other people but also raises broader ethical issues and questions.
The virus was first discovered by scientists in 1976, and several outbreaks of Ebola in the developing world killed 1,000 people through last year. Since April of this year it has killed over 900, and hundreds more are sick. Frighteningly, the epidemic is rapidly rising. Thousands are at risk.